Literature DB >> 8380983

Differential activation of p44mapk (ERK1) by alpha-thrombin and thrombin-receptor peptide agonist.

V Vouret-Craviari1, E Van Obberghen-Schilling, J C Scimeca, E Van Obberghen, J Pouysségur.   

Abstract

alpha-Thrombin (thrombin), a potent mitogen for CCL39 hamster lung fibroblasts, stimulates phosphoinositide-specific phospholipase C (PI-PLC) and inhibits adenylate cyclase via cleavage of a specific G-protein-coupled receptor (TH-R), recently cloned from human and hamster cells. This action can be entirely mimicked by the synthetic peptide SFFLRNP, referred to here as TMP (thrombin-mimicking peptide). TMP corresponds to the first seven amino acids of the new N-terminus generated by thrombin cleavage of the hamster TH-R. Although thrombin and TMP apparently generate identical early transmembrane signals, only thrombin is mitogenic on its own. TMP needs to be associated with fibroblast growth factor (FGF), a tyrosine kinase-activating growth factor, to induce cell-cycle re-entry. Here, we have examined the early and late phase of p44 MAP kinase (p44mapk) activation in G0-arrested CCL39 cells after stimulation by thrombin, TMP, FGF or TMP+FGF. We found that: (i) both thrombin and TMP rapidly activate p44mapk in a dose-dependent manner with maximum activation at around 5 min, (ii) after the initial burst of activation, a second and long-lasting wave of activation is observed in response to thrombin (10-100 nM) but not to TMP (up to 300 microM), (iii) FGF alone (25 ng/ml), like thrombin, rapidly and persistently activates p44mapk (20-fold at 5 min and about 3-fold after 2 h), (iv) TMP added together with FGF strongly potentiates the second and sustained phase of p44mapk activation. From these results we propose that: (1) thrombin-induced mitogenesis is mediated only in part by the TH-R recently cloned and (2) activation of p44mapk, in particular the long-lasting phase that correlates with DNA synthesis, is an obligatory event for cell-cycle re-entry.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380983      PMCID: PMC1132151          DOI: 10.1042/bj2890209

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

Authors:  T K Vu; D T Hung; V I Wheaton; S R Coughlin
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

2.  Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases.

Authors:  N Gómez; P Cohen
Journal:  Nature       Date:  1991-09-12       Impact factor: 49.962

3.  cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization.

Authors:  U B Rasmussen; V Vouret-Craviari; S Jallat; Y Schlesinger; G Pagès; A Pavirani; J P Lecocq; J Pouysségur; E Van Obberghen-Schilling
Journal:  FEBS Lett       Date:  1991-08-19       Impact factor: 4.124

Review 4.  Regulation of thrombin generation and functions.

Authors:  J W Fenton
Journal:  Semin Thromb Hemost       Date:  1988-07       Impact factor: 4.180

5.  Thrombin exerts a dual effect on stimulated adenylate cyclase in hamster fibroblasts, an inhibition via a GTP-binding protein and a potentiation via activation of protein kinase C.

Authors:  I Magnaldo; J Pouysségur; S Paris
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

6.  Strong and persistent activation of inositol lipid breakdown induces early mitogenic events but not Go to S phase progression in hamster fibroblasts. Comparison of thrombin and carbachol action in cells expressing M1 muscarinic acetylcholine receptors.

Authors:  K Seuwen; C Kahan; T Hartmann; J Pouyssegur
Journal:  J Biol Chem       Date:  1990-12-25       Impact factor: 5.157

7.  Tyrosine and threonine phosphorylation of an immunoaffinity-purified 44-kDa MAP kinase.

Authors:  J C Scimeca; R Ballotti; T T Nguyen; C Filloux; E Van Obberghen
Journal:  Biochemistry       Date:  1991-09-24       Impact factor: 3.162

8.  Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase.

Authors:  N G Anderson; J L Maller; N K Tonks; T W Sturgill
Journal:  Nature       Date:  1990-02-15       Impact factor: 49.962

9.  An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control.

Authors:  T G Boulton; G D Yancopoulos; J S Gregory; C Slaughter; C Moomaw; J Hsu; M H Cobb
Journal:  Science       Date:  1990-07-06       Impact factor: 47.728

10.  Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase).

Authors:  D M Payne; A J Rossomando; P Martino; A K Erickson; J H Her; J Shabanowitz; D F Hunt; M J Weber; T W Sturgill
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

View more
  34 in total

1.  Physical and functional interactions of Galphaq with Rho and its exchange factors.

Authors:  S A Sagi; T M Seasholtz; M Kobiashvili; B A Wilson; D Toksoz; J H Brown
Journal:  J Biol Chem       Date:  2001-02-06       Impact factor: 5.157

2.  Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1.

Authors:  Claire J Chalmers; Kathryn Balmanno; Kathryn Hadfield; Rebecca Ley; Simon J Cook
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

Review 3.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

Review 4.  Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.

Authors:  M D Hollenberg; K Mihara; D Polley; J Y Suen; A Han; D P Fairlie; R Ramachandran
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

5.  Structure-activity analysis of synthetic alpha-thrombin-receptor-activating peptides.

Authors:  E Van Obberghen-Schilling; U B Rasmussen; V Vouret-Craviari; K U Lentes; A Pavirani; J Pouysségur
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

6.  Differential regulation of extracellular signal-regulated protein kinase 1 and Jun N-terminal kinase 1 by Ca2+ and protein kinase C in endothelin-stimulated Rat-1 cells.

Authors:  K Cadwallader; J Beltman; F McCormick; S Cook
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

7.  Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase.

Authors:  J D Weber; D M Raben; P J Phillips; J J Baldassare
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

Review 8.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

9.  The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin.

Authors:  H S Suidan; K J Clemetson; M Brown-Luedi; S P Niclou; J M Clemetson; J Tschopp; D Monard
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

10.  Ligand-specific sequential regulation of transcription factors for differentiation of MCF-7 cells.

Authors:  Yuko Saeki; Takaho Endo; Kaori Ide; Takeshi Nagashima; Noriko Yumoto; Tetsuro Toyoda; Harukazu Suzuki; Yoshihide Hayashizaki; Yoshiyuki Sakaki; Mariko Okada-Hatakeyama
Journal:  BMC Genomics       Date:  2009-11-20       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.